Current Treatment of Uveal Melanoma. [PDF]
Hanratty K +3 more
europepmc +1 more source
Circulating Tumor Cells in Uveal Melanoma: Multi-Marker Detection and Association With Disease State. [PDF]
de Bruyn DP +14 more
europepmc +1 more source
Machine learning identifies glycosphingolipid signature linking immune dysregulation and clinical prognosis in uveal melanoma. [PDF]
Guo H, Li B, Zhang Z, Chen J.
europepmc +1 more source
Circulating tumor DNA accelerates diagnosis and treatment guidance for metastatic uveal melanoma with hepatic lesions not amenable to biopsy. [PDF]
Kissinger CR +5 more
europepmc +1 more source
Novel uveal Melanocyte cell lines display distinct features from uveal melanoma. [PDF]
Dalvin LA +7 more
europepmc +1 more source
Phase I trial of locoregional administration of autologous tumor-infiltrating lymphocytes in patients with uveal melanoma and liver metastases (the HAITILS trial). [PDF]
Nelson A +13 more
europepmc +1 more source
Statement of Retraction: MicroRNA-592 serves as a novel tumor suppressor in Uveal melanoma: bioinformatics analysis and in vitro cell function verification. [PDF]
europepmc +1 more source
Related searches:
Uveal melanoma is the most common primary intraocular malignancy in adults. It is associated with a high rate of distant tumor spread and consequent mortality. Unlike retinoblastoma, for which treatment advances over the last few decades have resulted in a dramatic improvement in survival, outcomes for patients with uveal melanoma remain unchanged ...
Seema, Kashyap +3 more
openaire +2 more sources
To determine the proportion of nondiagnosed uveal melanomas after evaluation by optometrists or ophthalmologists.Retrospective observational cohort study.Four hundred thirty-three ophthalmic oncology patients with uveal melanoma.This was a retrospective study of uveal melanoma patients from a single ophthalmic oncology center. We sent questionnaires to
Riley, Bove, Devron H, Char
openaire +2 more sources

